Search Results 211-220 of 16113 for enzyme papain
However, many people who have cancer that's linked to the BRCA gene don't respond to PARP inhibitors. Therefore, there is a pressing need to find new treatments ...
Identification of ENPP1 mutations causing GACI or ARHR2 has increased clinical relevance due to the recent development of ENPP1 enzyme replacement therapy ...
About this study. RATIONALE: Dasatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research samples ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Non-use of ßblockers/angiotensin converting enzyme inhibitors. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...
See contact information for the Rural Health Research Core in the Center for Clinical and Translational Science (CCaTS) at Mayo Clinic.
Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work ...
Mayo Clinic researcher Jonathan B. Hoyne, Ph.D., develops new laboratory tests for cancer, endocrine, autoimmune and neurological disorders.
The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and CA19-9 level in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go 3X as far to shape the future of healthcare.